ÈÐÑ-19, èìóäîí ìíîãî àæèîòàæà âîêðóã îñîáåííî íà ïîñëåäíèõ ñèìïîçèóìàõ êîòîðûå ÿ ïîñåòèë Ó÷àéêèí ÷óòü ëè ñ òðèáóíû íå ïðûãàë ðàñõâàëèâàÿ èìóäîí ... îäíî ìíåíèå îò GOREC ïîëó÷èëè åìó íðàâèòñÿ ó íàñ â îòäåëåíèè(àíãèíû+ðàçáîðêà) ïëþþòñÿ ïðè ýòèõ ñëîâàõ! ðàñêàæèòå î ñâîåì îïûòå êòî ïðèìåíÿë!

"...ñóììàðíàÿ äîçà îðãàíè÷åñêè ñâÿçàííîé ðòóòè â ÈÐÑ-19 ïðèìåðíî ðàç â 5 ïðåâûøàåò òó, ÷òî åù¸ äîïóñêàåòñÿ â íåêîòîðûõ âàêöèíàõ. Ñìåþ ïîëàãàòü, ÷òî èçðÿäíàÿ äîëÿ ïîëîæèòåëüíîãî òåðàïåâòè÷åñêîãî ýôôåêòà ÈÐÑ-19 (â òåõ ñëó÷àÿõ, êîãäà îí íàáëþäàåòñÿ), îáóñëîâëåíà àíòèìèêðîáíûì äåéñòâèåì ýòîãî êîíñåðâàíòà, à òàêæå ïðîòèâîâîñïàëèòåëüíîé è öèòîïðîòåêòèâíîé àêòèâíîñòüþ ãëèöèíà..."



1: Volgin AR, Demina IuV.

[Experience of using bacterial lysate IRS 19 for the prophylaxis of the diseases of respiratory organs in organized groups]

Zh Mikrobiol Epidemiol Immunobiol. 2005 May-Jun;(3): 82-4. Russian.

PMID: 16028523



2: Gunchikov MV, Vinnikov AK.

[Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts]

Vestn Otorinolaringol. 2001;(1): 40. Russian. No abstract available.

PMID: 11247247



3: Luchikhin LA, Beliakova LV, Gurov AV.

[Prevention and treatment of upper respiratory tract infections with IRS-19 and polydex with phenylephrine]

Vestn Otorinolaringol. 2000;(4): 54-7. Russian. No abstract available.

PMID: 11011582



4: Nowak D, Prozynski M, Pietras T, Stolarek R, Mazerant P, Leder M.

Effect of bacterial extract, IRS-19, on the concentration of hydrogen peroxide and myeloperoxidase activity in nasal washings of patients with chronic bronchitis.

Arch Immunol Ther Exp (Warsz). 1997; 45 (1): 67-72.

PMID: 9090443



5: Kaspar P, Petro W.

[Inhalative immunostimulation in patients with chronic bronchitis]

Z Hautkr. 1988; 63 Suppl 4: 64-6. German.

PMID: 3075383 [PubMed - indexed for MEDLINE]



Âîò, ñîáñòâåííî ãîâîðÿ, è âñÿ "íàó÷íàÿ áàçà" ýòîãî ïðåïàðàòà.